Novel pyrrolecarboxylic acid derivatives represented by the following formula:
where R¹ is a hydrogen atom, an alkyl group of 5 to 25 carbon atoms or an alkenyl group of 5 to 25 carbon atoms, R² is a hydrogen atom, a phenyl group or an optionally substituted alkyl group of 1 to 10 carbon atoms, and R³ is a hydrogen atom, an alkyl group of 5 to 25 carbon atoms or an alkenyl group of 5 to 25 carbon atoms, or pharmaceutically acceptable salts thereof are provided.
The compounds are highly effective in reducing the level of triglyceride or cholesterol in serum, and useful as an active ingredient of a pharmaceutical composition for treating hyperlipemia and arteriosclerosis.
由下式代表的新型
吡咯羧酸衍
生物:
其中 R¹ 是氢原子、5 至 25 个碳原子的烷基或 5 至 25 个碳原子的烯基,R² 是氢原子、苯基或 1 至 10 个碳原子的任选取代烷基,R³ 是氢原子、5 至 25 个碳原子的烷基或 5 至 25 个碳原子的烯基,或其药学上可接受的盐。
这些化合物在降低血清中
甘油三酯或
胆固醇水平方面非常有效,可用作治疗高脂血症和动脉硬化的药物组合物的活性成分。